Skip to content
FDA Approves New Label for Opioid Use Disorder Drug
2025-02-26
Feb. 25, 2025 — The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with their treatment. The FDA has approved an updated treatment protocol for a drug called Sublocade,Continue Reading
